The Rise of Private Equity in Gastroenterology Practices

Abstract: Private equity (PE) investment in gastroenterology practices has significantly increased over the past several years. Because PE firms are prevented legally from owning a medical […]

Advanced Combination Treatment With Biologic Agents and Novel Small Molecule Drugs for Inflammatory Bowel Disease

Abstract: The use of combination therapy with a biologic agent and immunosuppressant has well-established efficacy and safety and is common practice in the management of inflammatory […]

Potassium-Competitive Acid Blockers and Gastroesophageal Reflux Disease

G&H  How do potassium-competitive acid blockers differ from proton pump inhibitors? DA  Proton pump inhibitors (PPIs) are prodrugs that are not active as absorbed but are […]


Examining the New Definition of Hepatorenal Syndrome and the Role of Terlipressin

G&H  How common is hepatorenal syndrome, and what are its potential consequences? RB  Hepatorenal syndrome is the most serious complication of cirrhosis and portal hypertension and […]

Letter From the Editor: Examining Race and Ethnicity in Patients With Inflammatory Bowel Disease 

As Dr Marie L. Borum recounts in this month’s issue of Gastroenterology & Hepatology, it was frequently taught in the past that Black and Hispanic individuals […]

Update on Barrett Esophagus Diagnosis and Management

G&H  What has recent research revealed about the rise in esophageal adenocarcinoma despite screening and surveillance for Barrett esophagus? AC  Esophageal adenocarcinoma (EAC) has been increasing […]

Racial and Ethnic Disparities in Inflammatory Bowel Disease 

G&H  What are the prevalence and incidence rates of inflammatory bowel disease by race and ethnicity, and how have they changed? MB  The prevalence and incidence […]

Back to Archive
Millennium Medical Publishing, Inc